Fundraising Fox

Thrivebio

Beverly, US · Founded 2014 · Delaware corporation · 1 known investors

Thrive Bioscience develops the Thrive IQ software platform and CellAssist imaging systems that capture and analyze time-series morphological data on live cells, colonies, and organoids in culture. Its products produce ML/AI-ready phenotypic data sets for biologists and data scientists working in cell biology and bioprocessing.

Founders & leadership

TF
Thomas Forest FarbExecutive
GP
Gary Paul MagnantExecutive
MF
Michael Forest FinneyNamed on SEC filing
AP
Alan Philippe BlanchardNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$14.4M disclosed across 4 rounds · 2015–2017

$1.8MraisedAug 2017 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas Forest FarbExecutive Officer, Director
  • Michael FinneyDirector
  • Brock ReeveDirector
  • Alan Philippe BlanchardExecutive Officer, Director
  • Guy BroadbentDirector
Offering amount
$2.5M
Amount sold
$1.8M
Minimum investment
$100K
Proceeds to insiders
$264K
First sale
May 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$7.2MraisedMar 2017 · 36 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan Philippe BlanchardExecutive Officer, Director
  • Michael FinneyDirector
  • Thomas Forest FarbExecutive Officer, Director
  • Brock ReeveDirector
  • Guy BroadbentDirector
Offering amount
$10M
Amount sold
$7.2M
Minimum investment
$7.5K
Proceeds to insiders
$760K
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.2MraisedDec 2015 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan Philippe BlanchardExecutive Officer, Director
  • Michael FinneyDirector
  • Thomas Forest FarbExecutive Officer, Director
  • Brock ReeveDirector
  • Guy BroadbentDirector
Offering amount
$2.2M
Amount sold
$2.2M
Minimum investment
$7.5K
Proceeds to insiders
$350K
First sale
Nov 2015
Incorporated
Corporation, Massachusetts, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.3MraisedMay 2015 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas Forest FarbExecutive Officer, Director
  • Michael Forest FinneyDirector
  • Gary Paul MagnantExecutive Officer, Director
  • Alan Philippe BlanchardExecutive Officer, Director
Offering amount
$4M
Amount sold
$3.3M
Minimum investment
$20K
Proceeds to insiders
$285K
First sale
Apr 2015
Incorporated
Corporation, Massachusetts, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Thrivebio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Thrivebio do?
Thrive Bioscience develops the Thrive IQ software platform and CellAssist imaging systems that capture and analyze time-series morphological data on live cells, colonies, and organoids in culture. Its products produce ML/AI-ready phenotypic data sets for biologists and data scientists working in cell biology and bioprocessing.
Who are Thrivebio's investors?
Thrivebio's investors include Lauder Partners.
How much funding has Thrivebio raised?
Thrivebio has disclosed $14.4M raised across 4 rounds.
Where is Thrivebio headquartered?
Thrivebio is headquartered in Beverly, US.